Study of the Telomerase Vaccine GV1001 to Treat Patients With Inoperable Stage III Non-small Cell Lung Cancer (LucaVax)
This study is not yet open for participant recruitment.
Verified April 2012 by Kael-GemVax Co., Ltd.
Sponsor:
Kael-GemVax Co., Ltd.
Collaborator:
Quintiles
Information provided by (Responsible Party):
Kael-GemVax Co., Ltd.
ClinicalTrials.gov Identifier:
NCT01579188
First received: April 13, 2012
Last updated: April 18, 2012
Last verified: April 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is not yet open for participant recruitment. |
|---|---|
| Estimated Study Completion Date: | May 2016 |
| Estimated Primary Completion Date: | May 2016 (Final data collection date for primary outcome measure) |